Epigenetic Mechanisms Influencing Therapeutic Response in Breast Cancer

Amaia Arruabarrena-Aristorena1,2,3, Eneda Toska4,5

  • 1Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Bizkaia Technology Park, Derio, Spain.

Insights

Estrogen receptor-positive breast cancer treatments face resistance. Epigenetic changes drive tumor growth and impact therapy effectiveness, necessitating new strategies to overcome resistance.

Area of Science:

  • Oncology
  • Molecular Biology
  • Epigenetics

Background:

  • Most breast cancers are estrogen receptor-positive (ER+).
  • Targeting ER signaling improves survival but resistance develops, particularly in metastatic disease.
  • Epigenetic dysregulation is increasingly recognized in cancer development and progression.

Purpose of the Study:

  • To review advances in understanding chromatin-based mechanisms in breast cancer.
  • To explore how epigenetic alterations influence response to standard therapies.
  • To discuss novel therapeutic strategies for overcoming treatment resistance.

Main Methods:

  • Review of recent scientific literature on breast cancer epigenetics and therapy.
  • Analysis of chromatin modifiers and transcription factors in tumorigenesis.
  • Discussion of emerging epigenetic-based therapeutic approaches.

Main Results:

  • Epigenetic regulatory processes are key contributors to breast cancer initiation and progression.
  • Aberrant epigenetic mechanisms mediate resistance to endocrine therapies.
  • Chromatin modifications impact the efficacy of standard breast cancer treatments.

Conclusions:

  • Understanding epigenetic mechanisms is crucial for developing effective breast cancer therapies.
  • Targeting epigenetic pathways offers a promising strategy to overcome therapeutic resistance.
  • Combination therapies involving epigenetic agents and targeted treatments show potential for improved patient outcomes.

Related Concept Videos

Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Genomic Imprinting and Inheritance02:30

Genomic Imprinting and Inheritance

Diploid organisms inherit genetic material through chromosomes from both parents. Copies of the same gene are known as alleles. In most cases, both alleles are simultaneously expressed and allow various cellular processes to function optimally. If one of the alleles is missing or mutated, the expression of the other allele can compensate; however, this is not true for all genes.
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
35.2K